Literature DB >> 11585633

Tc1/Tc2 and Th1/Th2 balance in Asian and Western types of multiple sclerosis, HTLV-I-associated myelopathy/tropical spastic paraparesis and hyperIgEaemic myelitis.

H Ochi1, X M Wu, M Osoegawa, I Horiuchi, M Minohara, H Murai, Y Ohyagi, H Furuya, J Kira.   

Abstract

CD8+ T cells, like CD4+ T cells, can differentiate into at least two subsets with distinct cytokine patterns: Tc1 cells produce Th1-like cytokines and Tc2 cells produce Th2-like cytokines. To clarify the immunopathological roles of Tc1 and Tc2 cells in central nervous system (CNS) inflammation, we examined intracellular cytokines in CD8+ and CD4+ T cells by flow cytometry and analyzed the Tc1/Tc2 balance as well as the Th1/Th2 balance in 80 patients with various CNS inflammatory diseases, including 20 with optico-spinal multiple sclerosis (OS-MS), 21 with conventional MS (C-MS), 22 with human T-lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and 17 with hyperIgEaemic myelitis. Twenty-two healthy subjects were also examined as controls. Patients with OS-MS showed a significantly higher percentage of INF-gamma+IL-4- CD8+ T cells as well as CD4+ T cells and a significantly higher intracellular interferon-gamma (IFN-gamma)/interleukin-4 (IL-4) ratio both in CD8+ and CD4+ T cells throughout the relapse and remission phases than the healthy controls. Furthermore, the patients with OS-MS showed a significantly lower percentage of INF-gamma-IL-4+ CD4+ T cells as well as CD8+ T cells during the relapse phase than the healthy controls. On the other hand, the patients with C-MS showed a significantly higher percentage of IFN-gamma-IL-4+ CD8+ T cells in addition to more IFN-gamma+IL-4- CD4+ T cells during the relapse phase than the healthy controls. The HAM/TSP patients showed a significantly higher percentage of INF-gamma+IL-4- CD8+ T cells and a significantly higher intracellular IFN-gamma/IL-4 ratio in CD8+ T cells than the healthy controls. In contrast, in hyperIgEaemic myelitis, in addition to a significantly lower intracellular IFN-gamma/IL-4 ratio in CD4+ T cells, a tendency toward a lower intracellular IFN-gamma/IL-4 ratio in CD8+ T cells in comparison to the healthy controls was observed. These results clarified for the first time the distinct Tc1/Tc2 balance in each disease condition as follows: Tc1 cell response is predominant in OS-MS and HAM/TSP, while Tc2 cell response is predominant in hyperIgEaemic myelitis and at relapse phase of C-MS. Furthermore, our results suggest that CD8+ T cells play an adjunctive role in disease induction and the clinical course of MS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11585633     DOI: 10.1016/s0165-5728(01)00393-9

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  10 in total

1.  Fulminant Devic disease successfully treated by lymphocytapheresis.

Authors:  I Nozaki; T Hamaguchi; K Komai; M Yamada
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04-13       Impact factor: 10.154

2.  Eomesodermin driven IL-10 production in effector CD8+ T cells promotes a memory phenotype.

Authors:  John Reiser; Kavitha Sadashivaiah; Aki Furusawa; Arnob Banerjee; Nevil Singh
Journal:  Cell Immunol       Date:  2018-12-01       Impact factor: 4.868

3.  In vitro modulation of the multiple sclerosis (MS)-associated retrovirus by cytokines: implications for MS pathogenesis.

Authors:  Caterina Serra; Giuseppe Mameli; Giannina Arru; Stefano Sotgiu; Giulio Rosati; Antonina Dolei
Journal:  J Neurovirol       Date:  2003-12       Impact factor: 2.643

4.  Cytokine-chemokine and cognitive profile of multiple sclerosis patients with predominant optic nerve and spinal cord involvement.

Authors:  Melis Şen; Ece Akbayır; Özlem Mercan; Erdil Arsoy; Mehmet Gencer; Vuslat Yılmaz; Cem İsmail Küçükali; Erdem Tüzün; Recai Türkoğlu
Journal:  J Spinal Cord Med       Date:  2019-09-26       Impact factor: 1.985

5.  Where Do AQP4 Antibodies Fit in the Pathogenesis of NMO?

Authors:  Makoto Kinoshita; Yuji Nakatsuji
Journal:  Mult Scler Int       Date:  2012-03-12

6.  T-helper1/T-helper2 cytokine imbalance in the iris of patients with glaucoma.

Authors:  ManSin Wong; Ping Huang; Weiyi Li; Ying Li; Samuel S Zhang; Chun Zhang
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

7.  Peripheral blood T cell dynamics predict relapse in multiple sclerosis patients on fingolimod.

Authors:  Zi-Ye Song; Ryo Yamasaki; Yuji Kawano; Shinya Sato; Katsuhisa Masaki; Satoshi Yoshimura; Dai Matsuse; Hiroyuki Murai; Takuya Matsushita; Jun-ichi Kira
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240

8.  Differential Frequency of CD8+ T Cell Subsets in Multiple Sclerosis Patients with Various Clinical Patterns.

Authors:  Zahra Salehi; Rozita Doosti; Masoumeh Beheshti; Ehsan Janzamin; Mohammad Ali Sahraian; Maryam Izad
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

9.  The HTLV-1 gp21 fusion peptide inhibits antigen specific T-cell activation in-vitro and in mice.

Authors:  Etai Rotem; Omri Faingold; Meital Charni; Yoel A Klug; Daniel Harari; Liraz Shmuel-Galia; Alon Nudelman; Varda Rotter; Yechiel Shai
Journal:  PLoS Pathog       Date:  2018-05-04       Impact factor: 6.823

10.  Type 1 Cytotoxic T Cells Increase in Placenta after Intrauterine Inflammation.

Authors:  Jin Liu; Yang Liu; Snigdha Panda; Anguo Liu; Jun Lei; Irina Burd
Journal:  Front Immunol       Date:  2021-09-08       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.